Repare Therapeutics
RPTX
RPTX
82 hedge funds and large institutions have $491M invested in Repare Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 71 → 82 (+11)
1.43% more ownership
Funds ownership: 78.27% → 79.69% (+1.4%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
82
Holding in Top 10
4
Calls
$1.25M
Puts
$37K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$5.27M | |
| 3 | +$3.65M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$2.28M |
| 5 |
BlackRock
New York
|
+$701K |
Top Sellers
| 1 | -$5.88M | |
| 2 | -$3.97M | |
| 3 | -$3M | |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$2.05M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.78M |